Insider · CIK 0001231615

JEFFS ROGER

Reports to the SEC for 7 companies · MORRISVILLE, NC

sec.gov

Transactions

Companies

Filings

CIK

0001231615

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-13	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−2,505 sh	$71.39	−$179K	1,163,170
2026-07-13	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−32.7K sh	$71.52	−$2.34M	1,130,426
2026-07-10	LQDALiquidia Corp · Performance Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−14.3K sh	—	—	143,329
2026-07-10	LQDALiquidia CorpM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+13.8K sh	—	—	1,151,342
2026-07-10	LQDALiquidia Corp · Performance Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−13.8K sh	—	—	83,001
2026-07-10	LQDALiquidia CorpM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+14.3K sh	—	—	1,165,675
2026-06-11	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−286 sh	$249.12	−$71.2K	58,367
2026-06-10	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−286 sh	$246.18	−$70.4K	58,653
2026-06-08	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,429 sh	—	—	0
2026-06-08	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,429 sh	—	—	58,939
2026-06-05	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+1,721 sh	—	—	1,721
2026-05-27	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−6,428 sh	$62.18	−$400K	1,041,667
2026-05-26	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$60.38	−$1.51M	1,048,095
2026-05-22	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$61.52	−$1.54M	1,073,095
2026-05-21	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$61.13	−$1.53M	1,098,095
2026-05-20	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$61.30	−$1.53M	1,123,095
2026-05-19	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$58.65	−$1.47M	1,148,095
2026-05-18	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$56.77	−$1.42M	1,173,095
2026-05-15	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$57.04	−$1.43M	1,198,095
2026-05-14	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$58.62	−$1.47M	1,223,095
2026-05-13	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$56.29	−$1.41M	1,248,095
2026-05-12	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$54.04	−$1.35M	1,273,095
2026-05-11	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$41.50	−$1.04M	1,298,095
2026-05-08	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$42.14	−$1.05M	1,323,095
2026-05-07	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$42.09	−$1.05M	1,348,095
2026-05-06	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$40.78	−$1.02M	1,373,095
2026-05-05	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$40.10	−$1M	1,398,095
2026-04-17	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−18.8K sh	$40.60	−$765K	1,423,095
2026-04-16	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$40.31	−$1.01M	1,441,934
2026-04-15	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$40.14	−$1M	1,466,934
2026-04-14	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−3,300 sh	$40.00	−$132K	1,491,934
2026-04-13	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−32.7K sh	$38.37	−$1.26M	1,137,599
2026-04-10	LQDALiquidia CorpM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+13.8K sh	—	—	1,156,010
2026-04-10	LQDALiquidia Corp · Performance Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−13.8K sh	—	—	96,835
2026-04-10	LQDALiquidia CorpM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+14.3K sh	—	—	1,170,343
2026-04-10	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−21.4K sh	$40.12	−$860K	1,495,234
2026-04-10	LQDALiquidia Corp · Performance Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−14.3K sh	—	—	157,662
2026-04-09	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−25K sh	$40.12	−$1M	1,516,667
2026-01-16	LQDALiquidia CorpA Award	Director, Chief Executive Officer	AAward	+115K sh	—	—	1,152,872
2026-01-16	LQDALiquidia Corp · Performance Stock UnitsA Award	Director, Chief Executive Officer	AAward	+173K sh	—	—	173,016
2026-01-12	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−66.6K sh	$37.43	−$2.49M	1,037,528
2026-01-09	LQDALiquidia CorpM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+57.3K sh	—	—	1,104,138
2026-01-09	LQDALiquidia Corp · Performance Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−13.8K sh	—	—	110,669
2026-01-09	LQDALiquidia CorpM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+13.8K sh	—	—	1,046,806
2026-01-09	LQDALiquidia Corp · Performance Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−57.3K sh	—	—	171,995
2025-10-13	LQDALiquidia CorpS Sale	Director, Chief Executive Officer	SSale	−20.3K sh	$23.41	−$474K	1,032,973
2025-10-10	LQDALiquidia Corp · Performance Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−13.8K sh	—	—	124,502
2025-10-10	LQDALiquidia CorpM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+13.8K sh	—	—	1,053,234
2025-09-02	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−13.5K sh	$123.68	−$1.67M	57,510
2025-08-29	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−20K sh	$121.27	−$2.43M	70,974

Recent filings

Accepted (ET)
Jul 144
JEFFS ROGER0001104659-26-083619
SEC(opens sec.gov)
Jun 114
JEFFS ROGER0001193125-26-268202
SEC(opens sec.gov)
Jun 104
JEFFS ROGER0001193125-26-266437
SEC(opens sec.gov)
Jun 94
JEFFS ROGER0001193125-26-264030
SEC(opens sec.gov)
May 284
JEFFS ROGER0001104659-26-067540
SEC(opens sec.gov)
May 264
JEFFS ROGER0001104659-26-066415
SEC(opens sec.gov)
May 204
JEFFS ROGER0001104659-26-064695
SEC(opens sec.gov)
May 154
JEFFS ROGER0001104659-26-062852
SEC(opens sec.gov)

Companies

Address

419 DAVIS DRIVE, SUITE 100

MORRISVILLE, NC, 27560